Home » Newsletters » BioWorld

BioWorld

March 18, 1992

View Archived Issues

ECOGEN ACQUIRES REMAINDER OF PARTNERSHIP

Roberts Shareholders OK Yamanouchi Buy-In

INTERVENTION WITH IMRE COLUMN SUCCEEDS

GENSIA ADOPTS POISON PILL

BIOMIRA GETS RIGHTS TO CANCER PEPTIDE

TEVA EXPANDS PHARMACHEMICAL CAPACITY

CELLULAR TRANSPLANT COMPANY FILES IPO

DATA FAVORS ALZA ORAL DELIVERY SYSTEM

ELAN TO DEBUT WRIST-BORNE DRUG DELIVERY

COMPANY DEFECTS TO NEW AMEX MARKET

SYNTHETIC TAXOL 'EXCITINGLY CLOSE'

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.